What happens when a healthcare giant pours $2 billion into the heart of American innovation? Johnson & Johnson (J&J), a cornerstone of global health solutions, is making waves with a massive investment to transform U.S. biomanufacturing. Picture a nation where life-saving drugs are produced swiftly
Understanding the CDMO Industry and Thermo Fisher’s Role Imagine a world where the development of life-saving drugs hinges on partnerships that streamline innovation and production at an unprecedented scale, a reality embodied by the contract development and manufacturing organization (CDMO)
In the rapidly advancing realm of medical innovation, cell and gene therapies stand out as potential game-changers for treating life-threatening diseases, yet they face formidable obstacles on the path to market. The U.S. Food and Drug Administration (FDA) has increasingly postponed or denied
In a nation heavily reliant on a steady supply of life-saving medications, the stark reality that many pharmaceutical manufacturing facilities are situated in regions increasingly vulnerable to natural disasters raises profound concerns. From hurricanes tearing through coastal areas to wildfires
Every year, Europe faces the daunting challenge of managing 10 billion kilograms of textile waste, a staggering figure that translates into a potential market worth billions of euros at a value of 2 to 3 euros per kilogram, presenting not just an environmental burden but a remarkable economic
The North American packaging industry is experiencing an unprecedented surge of activity as major corporations channel substantial investments into expansions, facility upgrades, and innovative projects to address the escalating demand for packaging solutions. Across the United States and Canada,
